Navigation Links
Cell Therapeutics, Inc. (CTI) Shareholders Authorize Share Increase at Special Meeting of Shareholders
Date:1/28/2008

SEATTLE, Jan. 28 /PRNewswire-FirstCall/ -- Cell Therapeutics, Inc. (CTI) (Nasdaq and MTAX: CTIC) announced that in a special meeting today shareholders approved the proxy proposal amending and restating the Company's articles of incorporation to increase the number of authorized shares from 110 million to 210 million and to increase the number of authorized shares of common stock from 100 million to 200 million.

Louis A. Bianco, Chief Financial Officer at CTI, who chaired the meeting, said "The increase in the number of authorized shares of common stock provides CTI with flexibility needed to support the future growth of the business. I'd like to thank all of the shareholders who returned their proxies."

About Cell Therapeutics, Inc.

Headquartered in Seattle, CTI is a biopharmaceutical company committed to developing an integrated portfolio of oncology products aimed at making cancer more treatable. For additional information, please visit http://www.cticseattle.com.

This press release includes forward-looking statements that involve a number of risks and uncertainties, the outcome of which could materially and/or adversely affect actual future results. Specifically, the risks and uncertainties include risks related to the impact of the increase in authorized shares of stock and the future business growth of the Company as well as the risk factors listed or described from time to time in the Company's filings with the Securities and Exchange Commission including, without limitation, the Company's most recent filings on Forms 10-K, 8-K, and 10-Q. Except as may be required by law, CTI does not intend to (and expressly disclaims any such obligation to) update or alter its forward-looking statements whether as a result of new information, future events, or otherwise.

Media Contact:

Dan Eramian

T: 206.272.4343

C: 206.854.1200

Susan Callahan
'/>"/>

SOURCE Cell Therapeutics, Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related biology technology :

1. Velcura Therapeutics, Inc. Can Begin Clinical Trials Following Successful Investigational New Drug Application to U.S. FDA
2. Cell Therapeutics, Inc. (CTI) Prices $1.27 million (euros 856.000) Offering of Common Stock through Societe Generale
3. Cell Therapeutics, Inc. Announces Authorization to Publish Italian Listing Prospectus
4. Cell Therapeutics, Inc. (CTI) Hosts Conference Call to Discuss Update on Zevalin(R) Acquisition, CMS Reimbursement, and PIX301 Timeline
5. Pearl Therapeutics, Inc. Expands Its Senior Management Team With Top Talent in Clinical Development and Regulatory Affairs
6. Cell Therapeutics, Inc. (CTI) to Submit Marketing Authorization Application for XYOTAX(TM) for First-line Non-small Cell Lung Cancer Ahead of Schedule
7. Cell Therapeutics, Inc. Announces Issuance of $23.25 Million in New Convertible Senior Notes in Exchange for $36.08 Million of Existing Convertible Senior Subordinated and Subordinated Notes
8. ARYx Therapeutics, Inc. Announces Pricing of its Initial Public Offering
9. Bioenergy Life Science and Integrative Therapeutics, Inc. Form Exclusive Co-Marketing Alliance
10. Velcura Therapeutics, Inc. Appoints Industry Executive to Lead Regulatory Affairs
11. Cell Therapeutics, Inc. (CTI) BIO Presentation to Be Webcast

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/1/2009)...H, Mass., Dec. 1 Harvest Technolog...results from the company sponsored 60-patient clin...nter in Chennai, India using the company,s BMAC Sy...itical Limb Ischemia (CLI). Sri Ramachandra Medica...ated institution based in Chennai, India and one o...
(Date:12/1/2009)...rmer Majority Leader Richard Gephardt Brings Toget...otech Communities for "Best and Brightest Forum o...ec. 1 Several of New Je...s, research, medicine and technology gathered toda...ortance of medical innovation in New Jersey, and t...
(Date:12/1/2009)...OTA, Fla., Dec. 1 Expanding its Eu...hnics Inc. of Sarasota has appointed Lake Chemical... Lake is located near Birmingham, England. ,, ...ch serve the agricultural, waste water, and enviro...y and to open drain fields, and clean up industria...
(Date:12/1/2009)...NCISCO, Dec. 1 The Burrill Biotech... value it lost in October. The Select,s gain of 4....h for the general markets with the Dow up 6.5 perc...ins held firm in the final two trading days of the...nksgiving holiday shopping and Dubai,s reported de...
Breaking Biology Technology:Harvest Technologies Announces Trial Results in its India Study Using BMAC to Treat Patients With Non-Reconstructable Critical Limb Ischemia 2Harvest Technologies Announces Trial Results in its India Study Using BMAC to Treat Patients With Non-Reconstructable Critical Limb Ischemia 3New Jersey's Best and Brightest Minds Discuss Challenges Facing Medical Innovation, Call for Policies to Preserve U.S. Leadership in Research and Development 2New Jersey's Best and Brightest Minds Discuss Challenges Facing Medical Innovation, Call for Policies to Preserve U.S. Leadership in Research and Development 3New Jersey's Best and Brightest Minds Discuss Challenges Facing Medical Innovation, Call for Policies to Preserve U.S. Leadership in Research and Development 4New Jersey's Best and Brightest Minds Discuss Challenges Facing Medical Innovation, Call for Policies to Preserve U.S. Leadership in Research and Development 5Biotech Gets Back on Track in November 2Biotech Gets Back on Track in November 3Biotech Gets Back on Track in November 4
...today,received information from Danske Bank, that ...ivsforsikring and Danske Fund FCP - through,acquis...hares of a nominal,value of each DKK 1 correspondi...voting rights in Exiqon A/S., About Exiqon, Exiq...scientific,expertise in gene expression with our p...
...ications bear more than a passing resemblance to d...erally to capture all the colors of the spectrum, ...t from across the spectrum moves through optical c...rcuits contain dimensions measured in nanometers. ...andidate in electrical engineering at Lehigh Unive...
...WYE ) has,announced that Bernard Poussot, 56, Wyet...umed the additional position of Chairman of the Bo...t to a previously announced election by the,Compan...a succession plan,that began in April 2006 when Mr...man. In January 2007, he was named President and C...
Other Biology Technology:Using a grating with a grade, engineers trap a rainbow 2Using a grating with a grade, engineers trap a rainbow 3
(Date:12/1/2009)... United States, the other from Canada, put the sat...ck, on remote Ellesmere Island, only 600 miles fro...what these "North Pole wolves" do in the long, dar...he world., "We first encountered 9-year-old Brut... Geological Survey (USGS) wolf researcher who has ...
(Date:12/1/2009)...wire/ -- iQor, a global provider of business proce... 2009 InfoWorld 100 Awards Top 100 IT project of... This was the first submission for iQor. ,, "We...us list of companies," said Vikas Kapoor, presiden...ng the way we do business, allowing us to work fas...
(Date:12/1/2009)...ideo of individual breast tissue cells reveals a n...otein that cycles between two major compartments i...mplete view of the internal signals that cause bre...ancer and are targets of drug development. , Th... factors, travels back and forth between the nucle...
Breaking Biology News(10 mins):North Pole wolf emails locations to researchers 2North Pole wolf emails locations to researchers 3iQor Named to InfoWorld 100 List of Top IT Projects of 2009 2ERK's got rhythm: Protein that controls cell growth found to cycle in and out of cell nucleus 2ERK's got rhythm: Protein that controls cell growth found to cycle in and out of cell nucleus 3ERK's got rhythm: Protein that controls cell growth found to cycle in and out of cell nucleus 4The Jones Center for Diabetes 26amp 3B Endocrine Wellness Selects Retasure to Enhance Diabetes Care 54138 1The Jones Center for Diabetes 26amp 3B Endocrine Wellness Selects Retasure to Enhance Diabetes Care 54138 2UT Southwestern physicians bust myths about insulin 54134 1UT Southwestern physicians bust myths about insulin 54134 2Cumberland Pharmaceuticals Announces Pricing of Its Initial Public Offering of Common Stock 13480 1Cumberland Pharmaceuticals Announces Pricing of Its Initial Public Offering of Common Stock 13480 2
...t seems size does matters after all. But for flyin...ty of Chicago researchers. , In the May 15, 2005,...entists described the effects of size and behavior...als were better gliders. , "Despite their lack of ...rial locomotors," said lead scientist and author J...
...ohns Hopkins infectious disease specialists who ha...combat HIV and AIDS worldwide are warning that lim...al therapies currently being distributed in Africa... can least afford to pay for them. , In an article...h online June 28, infectious disease specialist Jo...
...n early type of antibiotic-resistant bacteria that...0s has re-emerged as one of the community-acquired...in The Lancet tomorrow (Saturday 2 April 2005). , ...at caused a pandemic 40-50 years ago could mean th...be more widespread than previously expected, warns...
Other Biology News:Researchers reveal secrets of flying snakes 2Researchers reveal secrets of flying snakes 3Hopkins AIDS experts issue warning about global efforts to provide drug therapies 2Hopkins AIDS experts issue warning about global efforts to provide drug therapies 3Hopkins AIDS experts issue warning about global efforts to provide drug therapies 4Community MRSA is re-emergence of 1950s pandemic, study suggests 2
Acridine orange, hemizinc salt from Research Organics, Inc.
Auto/Zyme Reagent Set from Biomeda Corporation
DAPI from Research Organics, Inc.
Agarose, high EEO, Molecular Biology Grade from Research Organics, Inc.
Biology Products: